Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis.

Daviss WB, Patel NC, Robb AS, McDERMOTT MP, Bukstein OG, Pelham WE, Palumbo D, Harris P, Sallee FR. Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis. J Am Acad Child Adolesc Psychiatry. 2008 Feb; 47(2):189-198.

View in: PubMed

authors with profiles

William Pelham

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support